Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

VIKING GLOBAL INVESTORS LP Create: Alert

All | News | Filings
Date FiledTypeDescription
07/19/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/16/2023 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 7.2% stake in Cazoo Group Ltd.
05/16/2023 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 7.2% stake in Cazoo Group Ltd.
04/27/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/21/2023 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 7.2% stake in Cazoo Group Ltd.
02/27/2023 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 7.2% stake in Cazoo Group Ltd.
11/25/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/10/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/04/2022 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 5% stake in Ginkgo Bioworks Holdings, Inc.
10/01/2021 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 22.8% stake in Ginkgo Bioworks Holdings, Inc.
07/15/2019 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 0% stake in Axovant Sciences Ltd.
07/12/2019 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 0% stake in Myovant Sciences Ltd.
07/12/2019 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 0% stake in Arbutus Biopharma Corporation
07/12/2019 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 0% stake in Urovant Sciences Ltd.
03/19/2019 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 58.2% stake in Axovant Sciences Ltd.
01/03/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/03/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/03/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/20/2018 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 65.2% stake in Axovant Sciences Ltd.
06/07/2018 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 731% stake in Axovant Sciences Ltd.
01/16/2018 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 29.1% stake in Arbutus Biopharma Corporation
10/17/2017 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 29.1% stake in Arbutus Biopharma Corporation
07/05/2017 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 69.8% stake in Axovant Sciences Ltd.
07/05/2017 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 29.1% stake in Arbutus Biopharma Corporation
06/14/2017 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 69.8% stake in Axovant Sciences Ltd.
06/14/2017 SC 13D/A VIKING GLOBAL INVESTORS LP reports a 29.1% stake in Arbutus Biopharma Corporation

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy